Home › Funds › Corvex Management › LAB
Corvex Management position in LAB
STANDARD BIOTOOLS INC · Industrials
Latest position (Q1 2026)44.34K sh
Reported value held$40.76K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 44.40K | $120.32K | New |
| Q2 2024 | 44.40K | $78.59K | Hold |
| Q3 2024 | 44.40K | $85.69K | Hold |
| Q4 2024 | 44.40K | $77.70K | Hold |
| Q1 2025 | 44.40K | $47.95K | Hold |
| Q2 2025 | 44.40K | $53.28K | Hold |
| Q3 2025 | 44.40K | $57.72K | Hold |
| Q4 2025 | 44.40K | $56.83K | Hold |
| Q1 2026 | 44.34K | $40.76K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- Viking Global Investors 58.65M sh · $48.25M · Q2 2026
- Vanguard Group 17.30M sh · $22.14M · Q4 2025
- BlackRock Inc 8.25M sh · $6.79M · Q2 2026
- Royce & Associates 4.53M sh · $3.72M · Q2 2026
- Geode Capital Management 3.90M sh · $3.21M · Q2 2026
- Millennium Management 3.51M sh · $2.89M · Q2 2026
- Morgan Stanley 2.83M sh · $2.33M · Q2 2026
- D. E. Shaw & Co 2.82M sh · $2.32M · Q2 2026
- Citadel Advisors 2.38M sh · $1.96M · Q2 2026
- Arrowstreet Capital 1.99M sh · $1.64M · Q2 2026
- Charles Schwab Investment Management 1.76M sh · $1.45M · Q2 2026